IP Library Granted Patent US 10,188,860
Granted Patent B2
US 10,188,860 · App. 15/225,741 · Granted Jan 29, 2019

Systems, methods and devices for a skull/brain interface

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,188,860
App. No.
15/225,741
Granted
Jan 29, 2019
Kind
B2
Abstract

Methods, devices, and systems induce neuromodulation by focusing a source of stimulation through a skull/brain interface in the form of an aperture formed in the skull, a naturally occurring fenestration in the skull, or a transcranial channel. Methods, devices, and systems identify where to locate skull/brain interfaces, accessories that can be used with the interfaces, and features for controlling stimulation delivered through the interfaces. Multiple indications for the skull/brain interfaces include diagnosis and treatment of neurological disorders and conditions such as epilepsy, movement disorders, depression, Alzheimer's disease, autism, coma, and pain.

Claims (22)

1. A system for introducing a form of neuromodulation to a patient, the system comprising:

at least one transcranial channel configured to be implanted in an aperture in the skull of the patient, and comprising an outer wall defining an interior cavity, and an ion-permeable substance at least partially filling the interior cavity, the ion-permeable substance configured to facilitate conduction of the form of neuromodulation;

at least one scalp electrode pad comprising an orienting feature configured to engage an ear of the patient to thereby position the at least one scalp electrode pad in a vicinity of the at least one transcranial channel near a target area of neural tissue;

a stimulation source electrically coupled to the at least one scalp electrode pad and configured to generate the form of neuromodulation and deliver the form of neuromodulation to the patient through the at least one scalp electrode pad and the at least one transcranial channel; and

a securing feature coupled to the at least one scalp electrode pad and configured to secure the at least one scalp electrode pad at the vicinity of the at least one transcranial channel.

2. The system of claim 1 , wherein the at least one scalp electrode pad is configured to be positioned in abutting contact with a scalp of the patient.

3. The system of claim 1 , wherein the target area of neural tissue is an occipital cortex, and the form of neuromodulation is anodal direct current stimulation.

4. The system of claim 1 , further comprising a control device, wherein:

the control device and the stimulation source are configured for wireless communication,

the stimulation source is configured to generate the form of neuromodulation in accordance with at least one operating parameter; and

the control device wirelessly controls the at least one operating parameter of the stimulation source.

5. The system of claim 4 , wherein the at least one operating parameter of the stimulation source corresponds to a strength of an electrical stimulation provided by the stimulation source.

6. The system of claim 4 , wherein the at least one operating parameter of the stimulation source corresponds to a number of electrical stimulations provided by the stimulation source during a period of time.

7. The system of claim 1 , further comprising a control device, wherein:

the control device is configured to enable a user-initiated delivery of the form of neuromodulation by the stimulation source; and

the stimulation source is configured to disallow the user-initiated delivery of the form of neuromodulation when a threshold amount of the form of neuromodulation is exceeded.

8. The system of claim 1 , wherein the form of neuromodulation is direct current stimulation and the stimulation source is configured to adjust the direct current to keep at least one parameter within a predetermined range while stimulation is being delivered.

9. The system of claim 1 , wherein the ion-permeable substance comprises a hydrogel.

10. The system of claim 1 , wherein the ion-permeable substance comprises a saline solution.

11. The system of claim 1 , wherein the ion-permeable substance comprises one or more of the following: porous silicone, a porous polyurethane, a saline solution, and a hydrogel.

12. The system of claim 1 , wherein the ion-permeable substance comprises a porous mass constructed by sintering together particles of a nonporous polymer, wherein the nonporous polymer comprises one or more of the following: a polyurethane, a polytetrafluoroethlene, a polyetheretherketone, a polyester, and a polyamide.

13. The system of claim 1 , wherein the ion-permeable substance is provided in an open-pore sponge.

Assignments (5)
SECURITY INTEREST Recorded Jun 25, 2025
From: NEUROPACE, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 071712/0422 →
RELEASE OF SECURITY INTEREST Recorded Jun 4, 2025
From: CRG SERVICING LLC AS SUCCESSOR TO CAPITAL ROYALTY PARTNERS II L.P., CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P., AND PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: NEUROPACE INC.
Reel/Frame 071495/0800 →
SECURITY INTEREST Recorded Sep 25, 2020
From: NEUROPACE, INC.
To: CRG SERVICING LLC
Reel/Frame 053885/0932 →
SECURITY INTEREST Recorded Apr 4, 2019
From: NEUROPACE, INC.
To: CRG SERVICING LLC
Reel/Frame 049466/0517 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2016
From: WINGEIER, BRETT; CHAO, DANIEL; PLESS, BENJAMIN; TCHENG, THOMAS
To: NEUROPACE, INC.
Reel/Frame 039426/0778 →